Antiepileptic and Anticonvulsant Drugs Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL ANTIEPILEPTIC AND ANTICONVULSANT DRUGS INDUSTRY

2.1 Summary about Antiepileptic and Anticonvulsant Drugs Industry

2.2 Antiepileptic and Anticonvulsant Drugs Market Trends

2.2.1 Antiepileptic and Anticonvulsant Drugs Production & Consumption Trends

2.2.2 Antiepileptic and Anticonvulsant Drugs Demand Structure Trends

2.3 Antiepileptic and Anticonvulsant Drugs Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Barbiturates and Analogues Thereof

4.2.2 Others

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 First Level Hospital

4.3.2 Two Level Hospital

4.3.3 Three Level Hospital

4.3.4 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Barbiturates and Analogues Thereof

5.2.2 Others

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 First Level Hospital

5.3.2 Two Level Hospital

5.3.3 Three Level Hospital

5.3.4 Others

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Barbiturates and Analogues Thereof

6.2.2 Others

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 First Level Hospital

6.3.2 Two Level Hospital

6.3.3 Three Level Hospital

6.3.4 Others

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Barbiturates and Analogues Thereof

7.2.2 Others

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 First Level Hospital

7.3.2 Two Level Hospital

7.3.3 Three Level Hospital

7.3.4 Others

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Barbiturates and Analogues Thereof

8.2.2 Others

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 First Level Hospital

8.3.2 Two Level Hospital

8.3.3 Three Level Hospital

8.3.4 Others

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Barbiturates and Analogues Thereof

9.2.2 Others

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 First Level Hospital

9.3.2 Two Level Hospital

9.3.3 Three Level Hospital

9.3.4 Others

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Novartis

10.1.2 Pfizer, Inc.

10.1.3 Roche

10.1.4 Sanofi

10.1.5 Merck & Co., Inc.

10.1.6 GlaxoSmithKline plc

10.1.7 Johnson & Johnson

10.1.8 AstraZeneca plc.

10.1.9 Eli Lilly and Company

10.1.10 Abbvie

10.1.11 AMGen

10.1.12 Teva Pharmaceutical Industries Ltd.

10.1.13 Bayer AG

10.1.14 Bristol-Myers Squibb

10.1.15 Astellas Pharma

10.1.16 Daiichi Sankyo

10.1.17 Abbott Laboratories

10.1.18 Yangtze River Pharmaceutical Group

10.2 Antiepileptic and Anticonvulsant Drugs Sales Date of Major Players (2017-2020e)

10.2.1 Novartis

10.2.2 Pfizer, Inc.

10.2.3 Roche

10.2.4 Sanofi

10.2.5 Merck & Co., Inc.

10.2.6 GlaxoSmithKline plc

10.2.7 Johnson & Johnson

10.2.8 AstraZeneca plc.

10.2.9 Eli Lilly and Company

10.2.10 Abbvie

10.2.11 AMGen

10.2.12 Teva Pharmaceutical Industries Ltd.

10.2.13 Bayer AG

10.2.14 Bristol-Myers Squibb

10.2.15 Astellas Pharma

10.2.16 Daiichi Sankyo

10.2.17 Abbott Laboratories

10.2.18 Yangtze River Pharmaceutical Group

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

1.Table Antiepileptic and Anticonvulsant Drugs Product Type Overview

2.Table Antiepileptic and Anticonvulsant Drugs Product Type Market Share List

3.Table Antiepileptic and Anticonvulsant Drugs Product Type of Major Players

4.Table Brief Introduction of Novartis

5.Table Brief Introduction of Pfizer, Inc.

6.Table Brief Introduction of Roche

7.Table Brief Introduction of Sanofi

8.Table Brief Introduction of Merck & Co., Inc.

9.Table Brief Introduction of GlaxoSmithKline plc

10.Table Brief Introduction of Johnson & Johnson

11.Table Brief Introduction of AstraZeneca plc.

12.Table Brief Introduction of Eli Lilly and Company

13.Table Brief Introduction of Abbvie

14.Table Brief Introduction of AMGen

15.Table Brief Introduction of Teva Pharmaceutical Industries Ltd.

16.Table Brief Introduction of Bayer AG

17.Table Brief Introduction of Bristol-Myers Squibb

18.Table Brief Introduction of Astellas Pharma

19.Table Brief Introduction of Daiichi Sankyo

20.Table Brief Introduction of Abbott Laboratories

21.Table Brief Introduction of Yangtze River Pharmaceutical Group

22.Table Products & Services of Novartis

23.Table Products & Services of Pfizer, Inc.

24.Table Products & Services of Roche

25.Table Products & Services of Sanofi

26.Table Products & Services of Merck & Co., Inc.

27.Table Products & Services of GlaxoSmithKline plc

28.Table Products & Services of Johnson & Johnson

29.Table Products & Services of AstraZeneca plc.

30.Table Products & Services of Eli Lilly and Company

31.Table Products & Services of Abbvie

32.Table Products & Services of AMGen

33.Table Products & Services of Teva Pharmaceutical Industries Ltd.

34.Table Products & Services of Bayer AG

35.Table Products & Services of Bristol-Myers Squibb

36.Table Products & Services of Astellas Pharma

37.Table Products & Services of Daiichi Sankyo

38.Table Products & Services of Abbott Laboratories

39.Table Products & Services of Yangtze River Pharmaceutical Group

40.Table Market Distribution of Major Players

41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e

42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

43.Table Global Antiepileptic and Anticonvulsant Drugs Market Forecast (Million USD) by Region 2021f-2026f

44.Table Global Antiepileptic and Anticonvulsant Drugs Market Forecast (Million USD) Share by Region 2021f-2026f

45.Table Global Antiepileptic and Anticonvulsant Drugs Market Forecast (Million USD) by Demand 2021f-2026f

46.Table Global Antiepileptic and Anticonvulsant Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f